Ten eleven translocation (TET) enzymes, including TET1, TET2 and TET3, convert 5-methylcytosine to 5-hydroxymethylcytosine 1 and regulate gene transcription 2-5 . However, the molecular mechanism by which TET family enzymes regulate gene transcription remains elusive 5,6 . Using protein affinity purification, here we search for functional partners of TET proteins, and find that TET2 and TET3 associate with O-linked b-N-acetylglucosamine (O-GlcNAc) transferase (OGT), an enzyme that by itself catalyses the addition of O-GlcNAc onto serine and threonine residues (O-GlcNAcylation) in vivo 7,8 . TET2 directly interacts with OGT, which is important for the chromatin association of OGT in vivo. Although this specific interaction does not regulate the enzymatic activity of TET2, it facilitates OGT-dependent histone O-GlcNAcylation. Moreover, OGT associates with TET2 at transcription start sites. Downregulation of TET2 reduces the amount of histone 2B Ser 112 GlcNAc marks in vivo, which are associated with gene transcription regulation. Taken together, these results reveal a TET2-dependent O-GlcNAcylation of chromatin. The double epigenetic modifications on both DNA and histones by TET2 and OGT coordinate together for the regulation of gene transcription.
the interaction between OGT and TET2 ( Fig. 1e and Supplementary  Fig. 2f ). In addition, recombinant TET3 catalytic domain also directly binds OGT ( Supplementary Fig. 2g ). Taken together, these results demonstrate that TET2 and TET3 form a complex with OGT both in vitro and in vivo.
TET enzymes were originally identified as homologues of JBP1 and JBP2 in Trypanosoma brucei; these two thymidine hydroxylases are involved in the synthesis of the modified DNA base b-D-glucosylhydroxymethyluracil (also known as base J) 1 . Synthesis of base J consists of two steps in which it is directly converted from thymidine bases incorporated in DNA strands. In the first step, JBP1 and JBP2 catalyse the oxidation of thymidine to hydroxymethyluracil. During the second step, a yet unknown enzyme transfers a glucose residue onto the hydroxyl group of hydroxymethyluracil to form base J 13 . We wondered whether OGT could catalyse the glycosylation on hydroxyl groups of 5-hydroxymethylcytosine (5hmC). To test this hypothesis, 5methylcytosine (5mC) was incubated with recombinant TET2 and OGT in vitro. However, OGT failed to convert 5hmC into any new base in vitro ( Supplementary Fig. 3a, b ). Co-expression of OGT with TET2 in cells did not alter the TET2-dependent 5hmC synthesis ( Supplementary Figs 3c and 4 ). Furthermore, we could not detect glycosylated 5hmC in vivo using mass spectrometry (Supplementary Figs 3d, e and 5). These results suggested that OGT does not affect TET2-dependent 5hmC synthesis.
Next, we asked whether TET2 regulates the function of OGT. We fractionated ES cell lysates using different salt concentrations and pH levels. A subset of TET2 and OGT could only be eluted from the chromatin using 300 mM NaCl or 0.2 M HCl, indicating that these TET2 and OGT species are tightly associated with the chromatin ( Supplementary Fig. 6a ). Interestingly, knockdown of TET2 by short hairpin RNA (shRNA) in ES cells abolished the chromatin-associated OGT, suggesting that TET2 may target OGT to chromatin (Supplementary Fig. 6a ). To verify this phenomenon, we used 293T cells stably expressing TET2. Because the exogenous TET2 level was much higher than the endogenous level ( Supplementary Fig. 7) , the chromatin-bound OGT was markedly increased in 293T cells stably expressing TET2 ( Supplementary Fig. 6b ). Moreover, because the D2 mutant of OGT abolished the interaction with TET2, only wild-type OGT but not the D2 mutant existed in the chromatin fraction, suggesting that the interaction with TET2 is important for the chromatin localization of OGT ( Supplementary Fig. 6c ). In addition, knockdown of OGT by shRNA did not significantly affect the chromatin retention of TET2 ( Supplementary Fig. 6d ). Collectively, these results suggest that TET2 recruits OGT to chromatin.
Recently, it has been shown that histones can be modified by OGT at different sites [14] [15] [16] [17] . In particular, OGT regulates O-GlcNAcylation of histone 2B (H2B) at Ser 112 in vivo 15 . Because TET2 targets OGT to chromatin, we wondered whether TET2 regulates OGT-dependent H2B O-GlcNAcylation. With a specific antibody for H2B Ser 112 GlcNAc, we found that H2B Ser 112 GlcNAc was significantly reduced in TET2-depleted ES cells ( Fig. 2a ). Moreover, TET2 also regulates O-GlcNAcylation of other histones ( Supplementary Fig. 8 ). Concurrent with TET2 overexpression inducing OGT association with chromatin, H2B Ser 112 O-GlcNAcylation was increased ( Fig. 2b) . Interestingly, the TET2 enzymatic-dead mutant (His1382Tyr/ Asp1384Ala) that still interacted with OGT also increased H2B Ser 112 O-GlcNAcylation, suggesting that the enzymatic activity of TET2 is not required for the regulation of H2B O-GlcNAcylation ( Fig. 2b and Supplementary Fig. 9 ). Moreover, only wild-type OGT but not the enzymatic-dead mutant of OGT (Gly482Ser) nor the D2 mutant lacking the interaction with TET2 could induce H2B S112 O-GlcNAcylation in vivo (Fig. 2c ). These data therefore suggest that the interaction between TET2 and OGT is important for OGTdependent histone glycosylation in vivo. To examine the mechanism by which TET2 boosts the enzymatic activity of OGT, we performed an in vitro glycosylation assay using wild-type OGT and its D2 mutant. Using histone octamers as the substrate, both wild-type OGT and the D2 mutant only weakly glycosylated histones. The enzymatic activity of wild-type OGT was indistinguishable from that of the D2 mutant as both proteins can auto-glycosylate themselves ( Supplementary  Fig. 10 ). Moreover, supplementation of TET2 did not affect the enzymatic activity of either wild-type OGT or the D2 mutant ( Fig. 2d ). However, when mono-nucleosomes were used as the substrates, supplementation of recombinant TET2 markedly increased the enzymatic activity of wild-type OGT but not the D2 mutant ( Fig. 2d and Supplementary Fig. 11 ), suggesting that the interaction with TET2 facilitates OGT recognition of the substrate. Although histones H3 and H4 were glycosylated in vivo, only GlcNAcylated H2A and H2B could be clearly detected in this in vitro glycosylation assay (Supplementary Fig. 11 ). One possibility is that glycosylated H2A and H2B suppresses H3 and H4 glycosylation by OGT. Alternatively, the glycosylation sites on H3 and H4 either in the histone octamer or as mono-nucleosomes are not well exposed to the enzyme. In contrast to many other enzymes, OGT only efficiently glycosylates the substrates that it associates with [18] [19] [20] [21] . Thus, it is likely that TET2 recognizes the chromatin and recruits OGT to the chromatin, and the chromatinassociated OGT glycosylates nucleosomal histones at its vicinity. Consistently, only TET2 but not OGT recognizes double-stranded DNA or mono-nucleosome with 5mC ( Supplementary Fig. 12 ).
To examine the distribution of OGT and TET2 on the chromatin of ES cells, we performed genome-wide chromatin immunoprecipitation (ChIP) sequencing analysis (ChIP-seq) using anti-OGT, anti-H2B Ser 112 GlcNAc and anti-mouse TET2 antibodies. We validated our ChIP-seq results using ChIP-quantitative PCR (qPCR) to examine 45 different loci that represent a broad range of ChIP-seq fragment counts ( Supplementary Fig. 13 ). Next, we compared the TET2 target genes with a published hmeDIP database 3 , and found that 47% of 5hmCpositive genes are bound by TET2 ( Supplementary Fig. 14a ). Most of the TET2 target genes are associated with high-and intermediatedensity CpG promoters ( Supplementary Fig. 14b , c), which are also positive for the trimethylated form of histone H3 at lysine 4 (H3K4me3) 22 ( Supplementary Fig. 14d ). Gene Ontology analysis showed that OGT, H2B Ser 112 GlcNAc and TET2 are involved in a Supplementary Fig. 1a . b, OGT interacts with TET2 and TET3 but not with TET1. SBP-tagged TET1-3 proteins were expressed and examined with indicated antibodies. Whole cell lysate (WCL) was used as the input. c, OGT interacts with TET2 endogenously in ES cells. Irrelevant IgG was used as the immunoprecipitation control (ctrl); PALB2 was used as the negative control. d, The DSBH domain of TET2 interacts with OGT. Deletion mutants of TET2 mutants were expressed. The F3 mutant containing the core-DSBH domain (catalytic domain) interacts with OGT. e, TPR5 and TPR6 of OGT interact with TET2. The D2 mutant of OGT, which lacks TPR5 and TPR6, abolished the interaction with TET2. f, OGT directly binds TET2. Sf9 cells were infected with baculoviruses encoding SBP-OGT and/or GST-TET2CD. The protein complex was purified by streptavidin beads or GST beads and examined by Coomassie blue staining.
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variety of basic cellular processes ( Supplementary Fig. 15 ). The analysis showed that OGT and H2B Ser 112 GlcNAc display a considerable overlap of target genes with TET2 ( Fig. 3a) , and similar binding profiles to TET2 at transcriptional start sites (TSS) (Fig. 3b , c). Moreover, the binding sites of OGT, H2B Ser 112 GlcNAc and TET2 have the highest density around TSS ( Fig. 3c ). Knockdown of TET2 markedly suppressed the recruitment of OGT to tested target genes and reduced the level of H2B Ser 112 GlcNAc at those loci ( Fig. 3d ). By contrast, knockdown of OGT had little effect on TET2 at these loci, suggesting that OGT does not contribute to the recruitment of TET2 to these loci ( Fig. 3d ). Next, we asked whether there was a correlation between TET2-mediated OGT targeting and the targeted gene transcription levels. In wild-type ES cells, we found that genes that were occupied by OGT and TET2 and enriched with H2B Ser 112 GlcNAc were associated with high levels of transcription in ES cells ( Fig. 3e and Supplementary Fig. 16 ). Moreover, we examined alterations to the gene transcription profile in TET2 knockdown ES cells. The percentage of downregulated genes that were occupied by OGT, H2B Ser 112 GlcNAc and TET2 was significantly higher than that of genes not occupied by OGT, H2B Ser 112 GlcNAc and TET2 ( Supplementary  Fig. 17 ). To validate these results, we performed qPCR to confirm the downregulation of a number of OGT, H2B Ser 112 GlcNAc and TET2 target genes ( Fig. 3f and Supplementary Fig. 18 ). In addition, we reconstituted TET2-depleted ES cells with the His1382Tyr/ Asp1384Ala mutant that abolishes the enzymatic activity of TET2. The His1382Tyr/Asp1384Ala mutant could not restore 5hmC at the TSS of a set of the TET2 and OGT common target genes. However, the His1382Tyr/Asp1384Ala mutant restored H2B Ser 112 GlcNAc and partially rescued the TET2 and OGT target gene expression ( Supplementary Fig. 19 ). These results indicate that OGTdependent histone O-GlcNAcylation contributes to TET2-dependent gene transcription. Taken together, here we have shown that TET2 and OGT form a complex, which might regulate gene transcription ( Supplementary  Fig. 20 ). Besides TET2, TET3 also interacts with OGT. Like TET2, TET3 might also target OGT to chromatin for gene transcription regulation. Owing to the different tissue distribution 9,23-25 , it is TET2 that targets OGT to the chromatin and regulates H2B O-GlcNAcylation in ES cells. Recently, it has been reported that H2B O-GlcNAcylation is associated with active TSS and positively regulates transcription 15 . However, 5hmC-enriched regions are associated with both transcriptional activation and repression [2] [3] [4] 26 . Because TET1 is associated with the transcriptional repression complex Sin3A, it is likely that TET1dependent 5hmC is associated with transcriptional repression 27 . By contrast, TET2 exists in a totally different complex with OGT but not Sin3A. Thus, the TET2-OGT complex might be involved in transcriptional activation in ES cells. Further analysis on each individual 5hmC-enriched locus could distinguish the identity of 5hmC in transcription regulation. Moreover, OGT also affects other histone modifications during mitosis 28 . It is possible that chromatin remodelling regulated by histone GlycNAcylation could be a general phenomenon in other biological processes. In addition to the transcription activation, 
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METHODS Plasmids and antibodies. For protein affinity purification and other analyses, full-length complementary DNAs of human TET1, TET2 and TET3 were cloned into the pS-Flag-SBP (SBP) vector. For generating internal-deletion mutants, OGT cDNA fragments were PCR amplified and cloned into pCMV-Myc. For generating truncation mutants, TET2 cDNA was PCR amplified and cloned into the SBP vector. TET2CD (amino acids 916-1921) was cloned into the SBP vector and pFast-Bac vector. Internal-deletion mutants of OGT, enzymatic-dead mutant (Gly482Ser) of OGT and enzymatic-dead mutant (His1382Tyr/Asp1384Ala) of TET2 were generated using the QuikChange site-directed mutagenesis kit (Stratagene). Rabbit anti-mouse TET2 antibody was raised against amino acids 1-200 of mouse TET2. Rabbit anti-mouse TET1 antibody was raised against the C terminus (amino acids 1500-2008) of mouse TET1. Anti-OGT antibody was purchased from Novaus. Anti-Flag, anti-Myc and anti-b-actin antibodies were purchased from Sigma. Anti-5hmC polyclonal antibody was purchased from Zymo Research. Antibodies against histone H2A, H2B, H3, H4, H3K4me3, H3K27me3 and H3 acetylated at Lys 14 (H3K14Ac) were purchased from Millipore. RL2 monoclonal antibody against O-GlcNAc was purchased from Abcam. CTD110.6 monoclonal antibody against O-GlcNAc was purchased from Covance. Monoclonal antibody against H2B Ser 112 GlcNAc was generated as described previously 15 .
Purification of TET-associated proteins. To search for binding partners of TET2 and TET3, we collected 1 l 293T cells stably expressing SBP-TET2 and SBP-TET3, respectively, and washed the cell pellets with PBS. Cells were lysed with 30 ml icecold NETN300 buffer (50 mM Tris-HCl, pH 7.4, 2 mM EDTA and 300 mM NaCl). The soluble fraction was incubated with 0.5 ml streptavidin-conjugated agarose beads. The beads were washed with NETN100 buffer (50 mM Tris-HCl, pH 7.4, 2 mM EDTA and 100 mM NaCl) three times. Associated proteins were eluted with 2 mM biotin (Sigma) in PBS, and further incubated with 50 ml S-protein-agarose beads (Novagen). The bound proteins were eluted with SDS sample buffer (20% glycerol, 120 mM Tris-HCl, pH 6.8, 4% SDS, 0.02% bromophenol blue and 2.5% b-mercaptoethanol), and analysed by 10% SDS-PAGE and mass spectrometry. Cells expressing empty vector were used as purification controls. Silver staining. Purified materials were load onto 8% SDS-PAGE for electrophoresis. The gel was fixed with 50% methanol, 10% acetic acid for 15 min, and followed by further fixation with 10% ethanol, 5% acetic acid for 6 min. For staining, the gel was agitated in 50 ml 20 mg l 21 Na 2 S 2 O 4 for 30 min, then stained in 50 ml AgNO 3 solution (100 mg AgNO 3 in 0.1% formaldehyde) for 30 min. After washed with ddH2O, the gel was treated with 50 ml image developer (3% Na 2 CO 3 , 50 ml 37% formaldehyde and 250 ml 0.2% sodium thiosulphate). The reaction was stopped using stop solution (12.5 ml acetic acid and 25 g Tris in 500 ml ddH2O) when clear bands were observed. Recombinant proteins. Recombinant proteins were purified from Sf9 insect cells. For generating baculovirus, DNA fragments containing full-length OGT, and deletion mutants of OGT, TET2CD and TET3CD were subcloned into the pFastBac vector with a GST or SBP tag. Baculoviruses were generated according to manufacturer's instructions (Invitrogen). After Sf9 cells were infected with baculoviruses for 48 h, the cells were collected, washed with PBS and lysed with ice-cold NETN100 buffer. The soluble fraction was incubated with glutathionesepharose beads (for GST-tag proteins) or streptavidin-conjugated beads (for SBP-tag proteins) and eluted with glutathione or biotin, respecitvely. To purify protein complex, Sf9 cells were co-infected with baculoviruses encoding GST-TET2CD and SBP-OGT for 48 h. The cells were then lysed and the soluble fraction was incubated with glutathione-sepharose beads or streptavidin-conjugated beads as indicated. Cell lysis, immunoprecipitation and western blotting. For immunoprecipitation, cells were lysed with ice-cold NETN300 buffer containing 10 mM NaF and 50 mM b-glycerophosphate. Supernatants were incubated with indicated antibodies and protein-G-conjugated sepharose beads (Amersham Pharmacia). Precipitates were washed five times with NETN100, subjected to SDS-PAGE and western blotting with indicated antibodies.
To examine the localization of OGT ( Supplementary Fig. 6 ), cell pellets were lysed with 400 ml NETN100 buffer. After centrifugation, the supernatants were named as 100 mM NaCl samples. The insoluble pellets were collected, washed with ice-cold PBS, and incubated with 400 ml NETN300 buffer on ice. After centrifugation, the supernatants were named as 300 mM NaCl samples. The remaining pellets were washed twice with ice-cold PBS and then treated with 200 ml 0.2 N HCl. The supernatants were neutralized with 200 ml Tris-HCl, pH 8.8, and named as 0.2 N HCl fractions. Twenty microlitres of each sample was loaded onto 7.5% SDS-PAGE gels and immunoblotted by indicated antibodies. The total amount of OGT was calculated by adding OGT from these three different fractions in each sample. The percentage of OGT in each fraction was presented.
Histone fraction. To examine histone glycosylation by immunoprecipitation and western blot, we followed a protocol from ref. 16 . In brief, cells were lysed in 20 mM Tris-HCl, pH 8.0, 600 mM NaCl, 0.5% NP-40, 0.5% SDS, 0.5% deoxycholate, 1 mM EDTA and 2 mM of the OGA inhibitor PUGNAc (Sigma). The cells were sonicated and clarified by centrifugation. The lysate was then diluted by NETN100 and histones were immunoprecipitated with the indicated antibodies.
To examine histone glycosylation by western blot, cells were lysed by NETN300 buffer with 2 mM PUGNAc. The pellets were washed twice with NETN300 and treated with 0.2 N HCl. After centrifugation, the supernatants were neutralized by the same volume of Tris-HCl, pH 8.8. Samples were examined by 10-20% gradient SDS-PAGE or 15% triton-acidic acid-urea (TAU) gel electrophoresis. TAU gel electrophoresis. Fifteen per cent TAU gel was prepared as reported 31 . In brief, the gel contained 15% acryl:bisacrylamide 60:0.4, 6 M urea, 5% acetic acid and 0.37% Triton X-100. Acid-extracted histones, histone octamers or mononucleosomes were dissolved in 23 loading buffer (8 M urea, 10% glycerol and 2.5% acetic acid) and loaded onto the gel. The gel was run in 5% acetic acid at 200 V for 140 min. For Coomassie blue staining, the gel was stained with Coomassie blue 250. For autoradiography, the gel was treated with EN3HANCE (PerkinElmer) before exposure to X-ray film. For western blot, the gel was washed twice in 300 ml of 50 mM acetic acid and 0.5% SDS for 30 min each time, and twice in 300 ml of transfer buffer (25 mM Tris, 192 mM glycine, 20% (v/v) methanol and 0.1% SDS) for 30 min each time. The electrotransfer reaction was carried out at a constant current of 400 mA for 2 h at room temperature. 6) ) were inserted into the pMSCV-puro-pSilencer vector. Generating retrovirus was carried out as previously described 35 . pMSCV-puro-shmock, pMSCV-puro-shOGT or pMSCV-puro-shTET2 vectors were used to transfect packaging cell line 293T with two other helper packaging plasmids pMD-MLV-OGP (gag-pol) and pVSV-G (env). Tissue culture supernatants from 293T packaging cells transfected with the above plasmids were collected. Viral particles were concentrated by centrifugation at 50,000g for 3 h and then added to the culture media of ES cells. The viralinfected cells were selected by puromycin for 72 h and then used in the following experiments. Similar results were obtained from shRNA treatment with different sequences. In vitro O-GlcNAcylation assay. Recombinant SBP-OGT protein (0.5 mg) was incubated with 2 mg substrates (histone octamers, mono-nucleosomes or 210bp 5hmC-containing oligonucleotides with sequence listed in Supplementary  Table 7 ) and 0.5 mM (0.5 mCi) UDP-[ 3 H]GlcNAc (from ARC) in 25 ml reaction buffer (50 mM Tris-HCl, pH 7.5, 12.5 mM MgCl 2 and 1 mM dithiothreitol (DTT)) for 1 h at 37 uC. The reaction was stopped by 10 mM EDTA. To detect potential DNA glycosylation, DNA was pulled down by streptavidin beads. The beads were subjected to scintillation counter measurement. b-glucosyltransferase (Zymo Research) was used as a positive control to produce GlcNAcylated-5hmC (5ghmC) following the protocol of Zymo Research, with UDP-[ 3 H]GlcNAc as the donor. For histone glycosylation analyses, the reaction was resolved with SDS-PAGE, and then subjected to autoradiography after incubation with EN3HANCE (from PerkinElmer). Nucleosome packaging was performed as described below with recombinant core histones purified from bacteria. Electrophoretic mobility shift assay. The 157-bp DNA oligonucleotide (Supplementary Table 7 ) containing 5mC was produced by PCR using dATP, dGTP, dmCTP and dTTP. The oligonucleotide was [ 32 P]-labelled at the 59 end by T4 DNA kinase and purified using a G50 spin column (Pharmacia Biotech). The labelled oligonucleotide (0.1 pmol) was incubated with GST (0.4 mg), GST-OGT (0.4 mg) and/or GST-TET2CD (0.1, 0.2 or 0.4 mg), in reaction buffer (50 mM HEPES, pH 7.9, 10 mM MgCl 2 , 50 mM NaCl, 75 mM Fe(NH 4 ) 2 and 0.1 mg ml 21 bovine serum albumin (BSA)) for 30 min at room temperature. The samples were loaded onto 6% native polyacrylamide gel and run at 150 V in 0.53 Trisborate-EDTA (TBE) buffer. The gels were then fixed with 30% methanol and 10% acetic acid and exposed to X-ray film.
For electrophoretic mobility shift assays using mono-nucleosomes, we generated oligonucleotides containing cytosine or 5mC by PCR. PCR products were end-labelled with 32 P and purified by gel electrophoresis. To generate mononucleosomes, labelled DNA oligonucleotides were incubated with core histones at a 1:1 molar ratio in a buffer containing 2 M NaCl and 1 mM DTT to a total volume of 30 ml. Mixtures were then serially dialysed against 2 M, 0.85 M, 0.65 M and 0.2 M NaCl in 10 mM Tris-HCl, pH 7.5, 1 mM EDTA and 1 mM DTT for 4-10 h at each step. Mono-nucleosomes were separated from free DNA by ultracentrifugation in 5-30% linear glycerol gradients. After centrifugation at 150,000g in a SW50.1 rotor for 18 h at 4 uC, gradient fractions were collected. Fractions
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containing mono-nucleosomes were pooled, and dialysed against 10 mM Tris-HCl, pH 8.0, and 1 mM DTT. For nucleosome-binding reactions, GST-OGT (0.2 mg) and GST-TET2CD (0.05, 0.1 or 0.2 mg) were incubated with 20 nM mono-nucleosomes in 20 ml, with final buffer conditions of 50 mM HEPES, pH 7.9, 10 mM MgCl 2 , 75 mM Fe(NH 4 ) 2 , 50 mM NaCl, 1 mM DTT, 1% glycerol and 1 mg ml 21 BSA. The reactions were incubated at room temperature for 1 h. Binding reactions were loaded onto 4% native polyacrylamide gels at 150 V in 0.53 TBE buffer. After electrophoresis, gels were dried and examined by autoradiography. ChIP assay and DNA immunoprecipitation assay. ChIP assays were preformed according to the protocol described by Upstate. ES cell DNA was sonicated to an average size between 300 and 600 bp. Solubilized chromatin was immunoprecipitated with antibodies against TET2, OGT, H2B Ser 112 GlcNAc, H3K4me3 and H3K27me3. Antibody-chromatin complexes were pulled-down using protein A-sepharose, washed and then eluted. After cross-link reversal and proteinase K treatment, immunoprecipitated DNA was extracted with phenol-chloroform, ethanol precipitated and treated with RNase. ChIP DNA was quantified using PicoGreen.
For hydroxymethylated DNA immunoprecipitaiton assay, genomic DNA was extracted using the Qiagen QIAamp DNa mini kit. The purified genomic DNA was sonicated using Diagenode Bioruptor 200. The DNA fragment size was determined by 2% agarose gel, and should be 200-800 bp. The samples were heatdenatured and mixed with 1 mg 5hmC antibody. The mixtures were incubated overnight at 4 uC and then pulled down by protein A-sepharose beads. The beads were extensively washed and digested by proteinase K. DNA was further purified by phenol-chloroform extraction and ethanol precipitation. 5hmC immunoprecipitated DNA was quantified using PicoGreen. ChIP sequencing. DNA fragments isolated from ChIP were repaired to blunt ends by T4 DNA polymerase and phosphorylated with T4 polynucleotide kinase using the END-IT kit (Epicentre). A single 'A' base was added to the 39 end with Klenow. Double-stranded adaptors (75 bp with a 'T' overhang) were ligated to the fragments with DNA ligase. Ligation products between 200 and 600 bp were gelpurified to remove unligated adaptors and subjected to 20 PCR cycles. Completed libraries were quantified with PicoGreen. For ChIP-seq analyses, the DNA libraries were analysed by Solexa/Illumina high-throughput sequencing. The read quality of each sample was determined by FastQC software. After prefiltering the raw data by removing sequence adapters and low-quality reads, the tags were mapped to the mouse genome (assembly mm9) by Bowtie software. Parameter settings were listed as follows: 2v, 3 (reported alignments with at most three mismatches), 25, 3 and 23, 3 (trim3 bases from 59 and 39 end to remove low-quality bases). Peak detection was performed using MACS software from Galaxy browser (http://www.galaxy.psu.edu). Parameters settings were as follows: IgG ChIP-seq aligned reads were used as control file, tag size with 25 bp, band width with 300 bp. Venn diagram analysis was performed with Galaxy browser. The peaks obtained from ChIP sequencing were matched to the annotated reference genome (mouse mm9) using Cisgenome 2.0. To view the peak density and position, Cisgenome 2.0 was used. The relative accumulations of tags around the TSS were performed using SEQMINER software. The TSS position of each gene was downloaded from the UCSC genome browser. Gene Ontology analysis was performed using Panther. All the statistics and plottings were obtained using the statistical program R. To compare TET2 and 5hmC, hmeDIP database was downloaded from NCBI 3 . A set of 30 PCR primer pairs (Supplementary Table 5 ) was designed to amplify 100-140-bp fragments from genomic regions showing a wide range of signals for TET2, OGT and H2B Ser 112 GlcNAc by ChIP-seq. ChIP-qPCR values reflect two independent ChIP assays; each was evaluated in duplicate by qPCR. Messenger RNA analysis. To examine gene expression, total RNA was purified from mouse ES cells using RNeasy (Qiagen). The RNA was reverse transcribed using TaqMan reverse transcription reagents from ABI. qPCR was carried out in 20 ml aliquots using SYBR green master mix (NEB) containing 10 nM 6carboxyfluorescein (Sigma) as a reference dye, 50 to 100 ng of cDNA and 2 mM primers. The reactions were performed on a Bio-Rad iCycler and quantified using the iCycler iQ software. The relative quantities of each mRNA were determined for each sample based on the threshold cycle (C T ) value normalized to the corresponding values for mouse Gapdh. Oligonucleotide sequences of the primers for qPCR assays are listed in the Supplementary Table 6 . All reactions were performed in triplicates.
RNA expression data for shCtrl and shTET2 ES cells were generated from polyA RNA using GeneChip Mouse Genome 430 arrays (Affymetrix) following Affymetrix procedures and analysis. The results were shown in Supplementary  Table 3 . The expression value of each transcript was showed in log 2 scale. The data analysis was performed using Cluster 3.0 and Java Treeview. In vitro 5hmC assay. To examine enzymatic activity of TET2 in vitro, 0.4 mg double-stranded DNA oligonucleotides (listed in Supplementary Table 7 ) that contain C, 5mC or 5hmC were incubated with 1 mg TET2CD or 1 mg TET2CD, together with 1 mg OGT proteins in the presence of 50 mM HEPES, pH 7.9, 100 mM NaCl, 75 mM Fe(NH 4 ) 2 , 2 mM ascorbate and 1 mM a-ketoglutate at 37 uC for 40 min. The DNA substrates were then purified by ethanol precipitation and digested with TapI. After the treatment with calf intestinal alkaline phosphatase, the DNA substrates were labelled with [c-32 P]ATP by T4 polynucleotide kinase, purified by ethanol precipitation and digested with 10 mg DNase I and 10 mg phosphodiesterase I. The samples were separated by thin layer chromatography (TLC) on PERcellulose TLC plates (Merck) using isobutyric acid:NH 4 OH:H 2 O at 66:2:20. After air drying, the TLC plates were exposed to X-ray film. Dot blotting assay. Genomic DNA isolated from 293T cells expressing TET2, OGT or both was denatured by 0.2 N NaOH and dotted on Hybond-N 1 nitrocellulose membrane (Amersham Pharmacia Biotech). After ultraviolet cross-linking, membranes were blocked overnight with 10% non-fat milk and 1% BSA in TBST (150 mM NaCl, 10 mM Tris, pH 8.0, and 0.1% Tween20) at 4 uC followed by 1 h incubation with either anti-5mC or anti-5hmC antibodies at room temperature. Membranes were washed four times with TBST, incubated with horseradish peroxidase (HRP)-conjugated goat anti-mouse or anti-rabbit antibodies (GE Healthcare), washed with TBST and developed using the ECL1 detection system (GE Healthcare). Mass spectrometry analysis. For 5ghmC standard, b-glucosyltransferase was used to produce 5ghmC following the protocol of Zymo Research using UDP-GlcNAc as the donor. The DNA was digested with DNA degradase plus (Zymo Research). The samples were subjected to liquid chromatography tandem mass spectrometry (LC-MS/MS). Liquid chromatography was performed using a 2.1 3 50 mm HSS T3 1.8 mm column (Waters), with gradient elution at a flow rate of 500 ml min 21 using 0.02% acetic acid in water as mobile phase A and methanol as mobile phase B. The gradient was (96% A 1 4% B) to (70% A 1 30 B) in 4.7 min. The elutes were directed to the mass spectrometer that was running in the product scan mode (60-500 m/z) selecting 461 as precursor ion (5ghmC). The collision energy used was 30 V.
For detecting 5ghmC or glucosylated-5hmC, genomic DNA from 293T cells expressing TET2 and OGT was digested as above and subjected to LC-MS/MS analysis using the same column and conditions as above. The mass spectrometer was running in multiple reaction monitoring mode, monitoring the transition of m/z 242.0 to 126.0 (5mC), m/z 258.0 to 142.0 (5hmC), 461.0 to 345.0 (5ghmC) and m/z 420.0 to 304.0 (glucosylated-5hmC), with the collision energy as 15 V.
